K Number
K221627
Device Name
PerfusionGo Plus
Date Cleared
2023-01-19

(227 days)

Product Code
Regulation Number
892.2050
Reference & Predicate Devices
Predicate For
N/A
AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
Intended Use

PerfusionGo Plus is an image processing software package to be used by trained professionals, including but not limited to physicians and medical technicians. The software runs on a standard "off-the-shelf" computer, and can be used to perform image processing, analysis, and communication of computed tomography (CT) perfusion scans of the brain. Data and images are acquired through DICOM-compliant imaging devices.

Device Description

PerfusionGo Plus is a standalone software package that is comprised of several modules including Login Module, Image List Module, Image Processing Module and Management Configuration Module. PerfusionGo Plus allows a DICOM-compliant device to send files directly from the image modality, through a node on a local network, or from a PACS server. The device is designed to automatically receive, identify, extract, and analyze a CTP study of the head embedded in DICOM image data. The software outputs parametric maps related to tissue blood flow (perfusion) and tissue blood volume that are written back to the source DICOM. Following such analysis, the results of analysis can be exported manually. The software allows for repeated use and continuous processing of data and can be deployed on a supportive infrastructure that meets the minimum system requirements.

PerfusionGo Plus image analysis includes calculation of the following perfusion related parameters:

  • Cerebral Blood Flow (CBF)
  • Cerebral Blood Volume (CBV)
  • Mean Transit Time (MTT)
  • Time-to-peak (TTP)
  • Residue function time-to-peak (Tmax)
  • Time-density curve (TDC)

The primary users of PerfusionGo Plus are medical imaging professionals who analyze dynamic CT perfusion studies. The results of image analysis produced by PerfusionGo Plus should be viewed through appropriate diagnostic viewers when used in clinical decision making.

AI/ML Overview

The provided document is a 510(k) Premarket Notification from the U.S. FDA for the device "PerfusionGo Plus". It primarily focuses on demonstrating substantial equivalence to a predicate device (Viz CTP, K180161) rather than detailing a specific clinical performance study with acceptance criteria and ground truth for a novel AI device.

Therefore, the document does not contain the information required to fully answer all aspects of your request, particularly regarding specific acceptance criteria for a clinical study, human-in-the-loop performance, or the detailed methodology for establishing ground truth from expert consensus or pathology data for a large test set.

However, I can extract the information that is present and indicate what is missing:

Information Present in the Document:

  • 1. A table of acceptance criteria and the reported device performance: Not explicitly provided as a formal table with acceptance criteria for a clinical study on device performance (e.g., accuracy against ground truth). The document states: "The results of performance testing showed that the PerfusionGo Plus achieved the pre-established performance goals for each perfusion parameters: CBF, CBV, MTT and Tmax." However, the specific pre-established performance goals (acceptance criteria) and the numerical results (reported device performance) are not detailed.
  • 2. Sample sized used for the test set and the data provenance:
    • Test Set Sample Size: Not explicitly stated. The document refers to "commercially available simulated datasets (digital phantom)".
    • Data Provenance: "commercially available simulated datasets (digital phantom) generated by simulating tracer kinetic theory." This implies synthetic data rather than real patient data from a specific country or collected retrospectively/prospectively.
  • 3. Number of experts used to establish the ground truth for the test set and the qualifications of those experts: Not applicable. The ground truth was established by "simulating tracer kinetic theory" for the digital phantoms, not by human experts.
  • 4. Adjudication method (e.g. 2+1, 3+1, none) for the test set: Not applicable, as ground truth was not expert-based.
  • 5. If a multi-reader multi-case (MRMC) comparative effectiveness study was done, If so, what was the effect size of how much human readers improve with AI vs without AI assistance: No, an MRMC study was not described. The document focuses on the standalone algorithm's performance against simulated ground truth. The device is described as "image processing software package to be used by trained professionals," suggesting human-in-the-loop use, but a study evaluating the impact of AI assistance on human readers is not presented.
  • 6. If a standalone (i.e. algorithm only without human-in-the-loop performance) was done: Yes, the described "performance testing" was of the standalone algorithm against simulated ground truth.
  • 7. The type of ground truth used: "commercially available simulated datasets (digital phantom) generated by simulating tracer kinetic theory, and includes a wide range of clinically relevant values of perfusion parameters as ground truth." This is simulated/theoretical ground truth.
  • 8. The sample size for the training set: Not mentioned. The document describes verification and validation testing, but does not specify a training set as would be typical for an AI model development. This might imply that the product is a rules-based image processing software rather than a machine learning/AI model that requires a training set. Given the context of "simulating tracer kinetic theory," it's highly likely to be a mathematical model implementation rather than a data-driven AI.
  • 9. How the ground truth for the training set was established: Not applicable, as no training set is described.

Summary of Missing Information (based on the typical requirements for AI/ML device approval when clinical studies are performed):

  • Specific numerical acceptance criteria for perfusion parameters (CBF, CBV, MTT, Tmax).
  • Specific numerical results for the device's performance against these criteria.
  • The exact sample size of the test set (number of simulated cases).
  • Details on how the "commercially available simulated datasets" were verified or validated themselves to represent clinical reality.
  • Any information regarding training data, which suggests this is not a traditional machine learning/AI device requiring such data, but rather an implementation of established tracer kinetic theory.
  • Any details on human expert involvement (e.g., radiologists) in ground truth establishment or human-in-the-loop performance studies.

Conclusion based on the provided document:

The PerfusionGo Plus device underwent performance testing against "commercially available simulated datasets (digital phantom) generated by simulating tracer kinetic theory." The ground truth for this testing was the theoretical values derived from these simulations. The document states that the device "achieved the pre-established performance goals" for perfusion parameters (CBF, CBV, MTT, and Tmax), demonstrating accurate computation. However, the exact numerical acceptance criteria and the quantitative results are not provided in this 510(k) summary. No details on training data, human expert ground truth, or human-in-the-loop studies are included, indicating that this submission likely pertains to a deterministic image processing algorithm rather than a data-driven AI/ML solution.

§ 892.2050 Medical image management and processing system.

(a)
Identification. A medical image management and processing system is a device that provides one or more capabilities relating to the review and digital processing of medical images for the purposes of interpretation by a trained practitioner of disease detection, diagnosis, or patient management. The software components may provide advanced or complex image processing functions for image manipulation, enhancement, or quantification that are intended for use in the interpretation and analysis of medical images. Advanced image manipulation functions may include image segmentation, multimodality image registration, or 3D visualization. Complex quantitative functions may include semi-automated measurements or time-series measurements.(b)
Classification. Class II (special controls; voluntary standards—Digital Imaging and Communications in Medicine (DICOM) Std., Joint Photographic Experts Group (JPEG) Std., Society of Motion Picture and Television Engineers (SMPTE) Test Pattern).